"The purpose of this document is to provide standard technical information to support Public Health Ontario’s (PHO’s) Annual Report on Vaccine Safety in Ontario, 2016 and related surveillance products. Technical information includes a brief background on vaccine safety surveillance in Canada, adverse event following immunization (AEFI) surveillance reporting processes in Ontario, and an in-depth explanation of analytic methods used in the report as well as notes on interpretation and limitations of AEFI surveillance data". - Annual Report on Vaccine Safety in Ontario, 2016: Technical Annex
Annual Report on Vaccine Safety in Ontario, 2016: Technical Annex
2016 Report available:
Updated version available:
Summary of National Advisory Committee on Immunization (NACI) Statement of January 28, 2022 : Rapid Response Guidance on the use of booster COVID-19 vaccine doses in adolescents 12-17 years of age
Summary of NACI statement of February 17, 2022: Recommendations on the use of Novavax Nuvaxovid COVID-19 vaccine
Resource Rating Breakdown
Ratings submitted by CANVax users for this resource are tallied to provide an average resource rating per category.